SCHEMBL2879698

SCHEMBL2879698

C[N+](C)[O-]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1070026 0.72
SCHEMBL83415 0.72
Nitromethane SCHEMBL525 0.72
Nitromethane SCHEMBL8771927 0.68
Nitromethane SCHEMBL1980079 0.68
Nitromethane SCHEMBL3012923 0.68
Nitromethane SCHEMBL1890507 0.68
Nitromethane SCHEMBL10735049 0.68
Nitromethane SCHEMBL8204968 0.68
Nitromethane SCHEMBL17162023 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4533657-A Analgesic dipeptide amides and method of use and composition thereof STERLING DRUG INC. (US) 1985-08-06 US claimed
US-4454120-A CONTAINING TYROSINE EITHER METHIONINE, O-METHIONINE, GLUTAMINE, OR SERINE STERLING DRUG INC. (US) 1984-06-12 US claimed
US-8338460-B2 3-({4-[2-(dimethylamino)ethoxy]phenyl}thio)-N-(3-methyl-1,2,4-thiadiazol-5-yl)-6-[(4-methyl-4H-1,2,4-triazol-3-yl)thio]pyridine-2-carboxamide; glucokinase activator; antidiabetic, obesity MSD K. K. (JP) 2012-12-25 US disclosed
EP-2077266-B1 2-PYRIDINECARBOXAMIDE DERIVATIVE HAVING GK-ACTIVATING ACTIVITY MSD KK (JP) 2012-07-25 EP disclosed
US-20100261699-A1 N-PYRAZOLE-2-PYRIDINE CARBOXAMIDE DERIVATIVE BANYU PHARMACEUTICAL CO., LTD. 2010-10-14 US disclosed
EP-2236507-A1 N-PYRAZOLE-2-PYRIDINECARBOXAMIDE DERIVATIVE Banyu Pharmaceutical Co., Ltd. (JP) 2010-10-06 EP disclosed
US-7807837-B2 Scalable synthesis of imidazole derivatives JANSSEN PHARMACEUTICA NV (BE) 2010-10-05 US disclosed
EP-2077266-A1 2-PYRIDINECARBOXAMIDE DERIVATIVE HAVING GK-ACTIVATING ACTIVITY BANYU PHARMACEUTICAL CO., LTD. (JP) 2009-07-08 EP disclosed
US-20090143591-A1 SCALABLE SYNTHESIS OF IMIDAZOLE DERIVATIVES JANSSEN PHARMACEUTICA NV (BE) 2009-06-04 US disclosed
EP-1747203-A4 SCALABLE SYNTHESIS OF IMIDAZOLE DERIVATIVES JANSSEN PHARMACEUTICA NV (BE) 2009-04-22 EP disclosed
US-7507756-B2 Scalable synthesis of imidazole derivatives JANSSEN PHARMACEUTICA N.V. (BE) 2009-03-24 US disclosed
WO-2002079168-A1 IMIDAZOLYL DERIVATIVES USEFUL AS HISTAMINE H3 RECEPTOR LIGANDS ORTHO MCNEIL PHARMACEUTICAL, INC. (US) 2002-10-10 WO disclosed
US-6365602-B1 FOR THERAPY OF DEPRESSION, ANXIETY, ASTHMA, PAIN, INFLAMMATION, URINARY INCONTINENCE AND OTHER DISEASE CONDITIONS ASTRA ZENECA AB (SE) 2002-04-02 US disclosed
EP-1097137-A1 N-SUBSTITUTED NAPHTHALENE CARBOXAMIDES AS NEUROKININ-RECEPTOR ANTAGONISTS AstraZeneca AB (SE) 2001-05-09 EP disclosed
WO-2000002859-A1 N-SUBSTITUTED NAPHTHALENE CARBOXAMIDES AS NEUROKININ-RECEPTOR ANTAGONISTS ASTRAZENECA AB (SE) 2000-01-20 WO disclosed
US-4658013-A CONTAINING ALANINE, PHENYLALANINE AND/OR TYROSINE OR METHIONINE STERLING DRUG INC. (US) 1987-04-14 US disclosed
EP-0187619-A2 1,3-Disubstituted tetrahydropyridines CIBA-GEIGY AG (CH) 1986-07-16 EP disclosed
US-4533657-A Analgesic dipeptide amides and method of use and composition thereof STERLING DRUG INC. (US) 1985-08-06 US disclosed
US-4454120-A CONTAINING TYROSINE EITHER METHIONINE, O-METHIONINE, GLUTAMINE, OR SERINE STERLING DRUG INC. (US) 1984-06-12 US disclosed
EP-0108036-A1 Benzopyranones CIBA-GEIGY AG (CH) 1984-05-09 EP disclosed